Bank of Baroda NMC Case: A Global Compliance Lesson

Written by Finnovate

Content Team

Bank of Baroda agreed to pay $600 million, approximately ₹5,700 crore, to settle legal proceedings connected with NMC Health, the UAE-based healthcare group that entered administration after billions of dollars of previously undisclosed debt emerged.

The case offers a wider lesson for Indian businesses expanding overseas. Compliance needs to shape customer checks, transaction structures, disclosures, internal approvals and recordkeeping from the beginning, not only after a dispute starts.

Bank of Baroda NMC settlement at a glance

Understanding the Bank of Baroda-NMC case

NMC Health was a UAE-based hospital operator founded by BR Shetty. It grew into one of the region’s largest private healthcare groups and was listed on the London Stock Exchange.

What began as an accounting crisis later became an international legal dispute involving NMC’s former management, connected parties, lenders and other institutions. Bank of Baroda became a defendant because of its banking relationships with NMC entities, BR Shetty and connected companies through its overseas operations.

What led to NMC Health’s collapse?

The crisis became public after Muddy Waters released a report on 17 December 2019 questioning NMC Health’s financial reporting, debt disclosures and corporate governance.

An independent review later identified discrepancies in bank statements and accounting records. NMC’s June 2019 financial statement had reported debt of approximately $2.1 billion. The UK Financial Conduct Authority later determined that the figure should have been around $6.2 billion.

By March 2020, NMC estimated its wider debt position at approximately $6.6 billion. The additional borrowing damaged confidence among lenders and investors, and administrators were appointed in April 2020.

Why was Bank of Baroda sued?

NMC’s joint administrators alleged that payments connected with the alleged scheme passed through accounts maintained with Bank of Baroda. They also claimed that certain deposit and overdraft arrangements helped conceal NMC’s actual debt position.

The administrators further alleged failures involving know-your-customer, anti-money laundering and other banking controls. Bank of Baroda denied wrongdoing and contested the claims.

What did the $600 million settlement change?

The trial before the ADGM Court began on 23 March 2026. Bank of Baroda announced the settlement on 2 July 2026 after reaching an agreement with NMC’s joint administrators.

The payment limited the bank’s liability in the relevant proceedings and brought the ADGM case to an end. The English proceedings were also being discontinued.

The agreement contained no admission of liability or wrongdoing. Bank of Baroda said the settlement avoided prolonged litigation, uncertainty and associated costs.

What the settlement does and does not establish

The allegations explain why the dispute became serious. The settlement terms explain why those allegations cannot be presented as proven findings against Bank of Baroda.

The case in six dates

1. December 2019Muddy Waters questioned NMC Health’s financial reporting and debt disclosures.
2. February 2020An independent review identified discrepancies in bank statements and accounting records.
3. March 2020NMC disclosed billions of dollars in additional debt.
4. April 2020Administrators were appointed.
5. March 2026The trial commenced before the ADGM Court.
6. July 2026Bank of Baroda announced the $600 million settlement.

Why this case matters beyond one bank

The Ranbaxy case offers an earlier warning

In 2008, Daiichi Sankyo acquired control of Ranbaxy through a transaction valued at approximately $4.6 billion. A Singapore-seated arbitral tribunal later awarded Daiichi approximately ₹2,562.78 crore in principal damages after findings of fraudulent misrepresentation and concealment connected with regulatory information provided during the acquisition.

The comparison is narrow but relevant. Incomplete regulatory disclosure during a cross-border transaction can create legal and financial consequences long after the deal closes.

Five compliance checks before an Indian business goes global

The lesson from these cases is not that every international transaction will lead to litigation. It is that controls need to work across countries, teams, systems and decision-making levels.

Strong compliance reporting also needs to move beyond activity counts. Boards gain more value from information on unresolved high-risk cases, repeated exceptions, delayed reviews and decisions approved despite internal concerns.

Compliance is part of global execution

Indian companies have built global businesses through technology, talent, cost advantages and operational speed. Sustainable expansion also requires governance systems that remain effective across jurisdictions.

The Bank of Baroda settlement shows how a disputed compliance process can create substantial exposure without producing a final finding of wrongdoing. The Ranbaxy case shows how incomplete regulatory disclosure can follow a transaction for years.

Compliance is therefore not separate from global growth. It is part of the operating system that allows global growth to last.

Key takeaways

• Bank of Baroda settled the NMC Health proceedings for $600 million, approximately ₹5,700 crore, without admitting liability or wrongdoing.
• NMC’s June 2019 statement reported debt of approximately $2.1 billion, while the FCA later determined that the figure should have been around $6.2 billion.
• The administrators alleged failures involving transaction structuring, KYC, AML and other controls. The settlement did not establish those allegations through a final judgment.
• Cross-border compliance depends on local regulatory mapping, independent escalation, transaction review and reliable records.
• The Ranbaxy dispute shows that incomplete regulatory disclosure during an overseas acquisition can create long-running consequences.

FAQs

1. Did Bank of Baroda admit wrongdoing in the NMC case?

No. Its stock exchange disclosure states that the settlement was reached without any admission of liability or wrongdoing.

2. How much undisclosed debt did NMC Health have?

NMC reported approximately $2.1 billion of debt for June 2019. The FCA later determined that the figure should have been around $6.2 billion, a difference of approximately $4.1 billion.

3. Why was Bank of Baroda involved in the NMC case?

Bank of Baroda had banking relationships with NMC entities, BR Shetty and connected companies. NMC’s administrators alleged that certain accounts and financing arrangements involving the bank were connected with the concealment of NMC’s debt, allegations that the bank denied.

4. What is the main lesson for Indian companies expanding overseas?

Compliance systems need to satisfy the rules of each market in which the company operates. Policies need to be supported by working controls, documented decisions and records that can be retrieved if regulators or courts later examine a transaction.

Sources

• Bank of Baroda stock exchange disclosure dated 2 July 2026
• UK Financial Conduct Authority final notice concerning NMC Health
• ADGM Court judgment on disclosure applications involving Bank of Baroda and BR Shetty
• Daiichi Sankyo disclosure on completion of the Ranbaxy acquisition
• Supreme Court of India judgment concerning enforcement proceedings in the Daiichi Sankyo matter

Disclaimer: This article is for general information and educational purposes only. It does not constitute legal, regulatory or investment advice, a recommendation, or an offer to buy or sell any security or financial instrument. Legal proceedings, regulatory requirements and compliance obligations depend on the facts and jurisdiction involved. Businesses may consult qualified legal and compliance professionals before acting on matters discussed in this article. Banking and equity investments are subject to applicable risks.